Skip to content
IFAI

Eli Lilly

Company2 stories

  1. AI toolsReach 31

    Eli Lilly opens its $1B drug discovery models to biotechs

    Eli Lilly just launched TuneLab, an AI platform giving biotech firms access to drug discovery models trained on over $1B worth of proprietary research data. The setup uses federated learning so startups can leverage Lilly's predictive chemistry models without exposing their own intellectual property.

  2. ResearchReach 31

    AI is learning to design life-saving drugs from scratch

    Pharma and tech giants like Eli Lilly and Nvidia see generative AI taking over drug discovery within a few years. By treating molecules and proteins like words in a sentence, AI can generate candidates in minutes that would take labs a year to synthesize, cutting research timelines from years to months. The real bottleneck remains human clinical trials.